Search results for "type"

showing 10 items of 10618 documents

Comment on: Comparative characteristics of older people with type 1 diabetes treated with continuous subcutaneous insulin infusion or insulin injecti…

2020

medicine.medical_specialtyEndocrinology Diabetes and MetabolismMEDLINEGermanEndocrinologyInsulin Infusion SystemsInternal medicineInternal MedicineMedicineHumansHypoglycemic AgentsInsulinRegistriesInsulin injectionAgedAged 80 and overType 1 diabetesbusiness.industrymedicine.diseaselanguage.human_languageSubcutaneous insulinDiabetes Mellitus Type 1AustrialanguagebusinessOlder peopleDiabetic medicine : a journal of the British Diabetic Association
researchProduct

Small, dense low-density-lipoproteins and the metabolic syndrome.

2006

Small, dense low-density-lipoproteins (LDL) are associated with increased risk for cardiovascular diseases and diabetes mellitus and a reduction in LDL size has been reported in patients with coronary and non-coronary forms of atherosclerosis. LDL size has been accepted as an important predictor of cardiovascular events and progression of coronary artery disease as well as an emerging cardiovascular risk factor by the National Cholesterol Education Program Adult Treatment Panel III. Small, dense LDL, with elevated triglyceride levels and low HDL-cholesterol concentrations, constitute the 'atherogenic lipoprotein phenotype (ALP)', a form of atherogenic dyslipidemia that is a feature of type …

medicine.medical_specialtyEndocrinology Diabetes and MetabolismMyocardial InfarctionCoronary DiseaseType 2 diabetesmetabolic syndromeCoronary artery diseasechemistry.chemical_compoundEndocrinologyatherosclerosipreventionRisk FactorsInternal medicineDiabetes mellitusInternal MedicinemedicineHumansParticle SizeRisk factorNational Cholesterol Education ProgramTriglycerideVascular diseasebusiness.industrydense LDLsmallAtherosclerosismedicine.diseaseLipoproteins LDLEndocrinologyDiabetes Mellitus Type 2chemistrydiabeteCardiologylipids (amino acids peptides and proteins)Metabolic syndromebusiness
researchProduct

Genetic and environmental aspect of polycystic ovary syndrome.

2004

Polycystic ovary syndrome (PCOS) is a heterogeneous syndrome determined in most patients by the association of two main factors: hyperandrogenism and insulin resistance. These characters are probably independent of each other and seem to be inherited by several different mechanisms. In some patients homozygous gene alteration has been found but in most patients PCOS seems to be determined by the association of gene polymorphisms that are common in the general population but alone are unable to determine phenotypic consequences. Alteration of genes that regulate the initial steps of ovarian steroidogenesis is probably the main causal factor of hyperandrogenism. Insulin resistance may be the …

medicine.medical_specialtyEndocrinology Diabetes and MetabolismPopulationBiologyEatingEndocrinologyInsulin resistanceInternal medicineInsulin receptor substratemedicineHumansGenetic Predisposition to DiseaseObesityeducationGeneeducation.field_of_studyHyperandrogenismmedicine.diseaseObesityPhenotypePolycystic ovaryEndocrinologyFemaleInsulin ResistanceEnergy MetabolismHyperandrogenismPolycystic Ovary SyndromeJournal of endocrinological investigation
researchProduct

Clinical inertia is the enemy of therapeutic success in the management of diabetes and its complications: A narrative literature review

2020

AbstractDiabetes mellitus is a chronic disease characterized by high social, economic and health burden, mostly due to the high incidence and morbidity of diabetes complications. Numerous studies have shown that optimizing metabolic control may reduce the risk of micro and macrovascular complications related to the disease, and the algorithms suggest that an appropriate and timely step of care intensification should be proposed after 3 months from the failure to achieve metabolic goals. Nonetheless, many population studies show that glycemic control in diabetic patients is often inadequate. The phenomenon of clinical inertia in diabetology, defined as the failure to start a therapy or its i…

medicine.medical_specialtyEndocrinology Diabetes and MetabolismPopulationTherapeutic inertiaDiseaseReviewDiabetes mellitusEpidemiologyType 2 diabetes mellitusInternal MedicinemedicineIntensive care medicineeducationlcsh:RC620-627Therapeutic inertiaGlycemiceducation.field_of_studyClinical inertia Diabetes care Italian association of medical diabetologists Therapeutic inertia Type 2 diabetes mellitusbusiness.industryType 2 Diabetes Mellitusmedicine.diseaselcsh:Nutritional diseases. Deficiency diseasesClinical inertiaMetabolic control analysisItalian association of medical diabetologistsbusinessDiabetes care
researchProduct

Effects of aerobic exercise and diet intervention on glycaemic control and liver fat content in men and women aged 50–65 years with prediabetes and n…

2016

Abstract Background Prediabetes and non-alcoholic fatty liver disease precede development of type 2 diabetes; however, appropriate lifestyle interventions might help to prevent such progression. We aimed to test whether aerobic exercise training and a high-fibre diet can reduce hepatic fat content and increase insulin sensitivity in individuals with prediabetes and non-alcoholic fatty liver disease. Methods We did a randomised controlled trial in seven clinics in Yangpu district, Shanghai, China. We recruited individuals aged 50–65 years with impaired fasting glucose (5·6–6·9 mmol/L) or impaired glucose tolerance (2 h glucose 7·8–11·0 mmol/L) and diagnosed non-alcoholic fatty liver disease.…

medicine.medical_specialtyEndocrinology Diabetes and MetabolismPopulationType 2 diabeteslaw.inventionImpaired glucose tolerance03 medical and health sciences0302 clinical medicineEndocrinologyRandomized controlled triallawInternal medicineInternal MedicinemedicineAerobic exercise030212 general & internal medicinePrediabeteseducationeducation.field_of_studybusiness.industryFatty livermedicine.diseaseImpaired fasting glucosePhysical therapybusiness030217 neurology & neurosurgeryThe Lancet Diabetes & Endocrinology
researchProduct

From obesity to Alzheimer's disease through insulin resistance

2021

Alzheimer's disease is one of the most frequent forms of dementia. It is a progressive neurodegenerative disease, characterized by presence of amyloid plaques and neurofibrillary tangles in the brain. Obesity is regarded as abnormal fat accumulation with deleterious impact on human health. There is full scientific evidence that obesity and the metabolic comorbidities (e.g., insulin resistance, hyperglycaemia, and type 2 diabetes) are related to Alzheimer's disease and likely in the causative pathway. Numerous studies have identified several overlapping neurodegenerative mechanisms, including oxidative stress, mitochondrial dysfunction, and inflammation. In this review, we present how obesit…

medicine.medical_specialtyEndocrinology Diabetes and MetabolismType 2 diabetesmedicine.disease_causeEndocrinologyInsulin resistanceDownregulation and upregulationAlzheimer DiseaseInternal medicineDiabetes mellitusInternal MedicinemedicineHumansDementiaObesityNeurodegenerationInflammationbusiness.industryNeurodegenerationBrainInsulin resistanceAlzheimer's diseasemedicine.diseaseEndocrinologyDiabetes Mellitus Type 2LipotoxicitybusinessOxidative stressJournal of Diabetes and its Complications
researchProduct

Liraglutide Improves Cardiovascular Risk as an Add-on to Metformin and Not to Insulin Secretagogues in Type 2 Diabetic Patients: A Real-life 48-Month…

2017

INTRODUCTION: Although liraglutide is widely recognized to have glycemic and extra-glycemic effects, few studies have compared these effects in relation to hypoglycemic treatment starting from the diagnosis of diabetes. We evaluated the effectiveness of liraglutide in reducing the Framingham risk score (FRS) and visceral adiposity index (VAI) in relation to first-line hypoglycemic treatment from diagnosis of type 2 diabetes, continued without any changes. METHODS: We selected 105 diabetic outpatients who were treated with liraglutide for at least 48 months as an add-on therapy to metformin alone (group A, n = 52) or insulin secretagogues (group B, n = 53) from diagnosis time. RESULTS: Altho…

medicine.medical_specialtyEndocrinology Diabetes and Metabolismmedicine.medical_treatment030209 endocrinology & metabolismType 2 diabetes030204 cardiovascular system & hematologyGastroenterologySettore MED/13 - Endocrinologia03 medical and health sciences0302 clinical medicineDiabetes mellitusInternal medicineInternal MedicinemedicineGlycemicFramingham Risk Scorebusiness.industryLiraglutideBrief ReportInsulinDiabetesLiraglutideCardiovascular riskmedicine.diseaseliraglutide diabetesMetforminEndocrinologyBlood pressureVisceral adipositybusinessmedicine.drug
researchProduct

Endothelial Function and Arterial Stiffness in Uncomplicated Type 1 Diabetes and Healthy Controls and the Impact of Insulin on These Parameters durin…

2007

BACKGROUND In addition to its role in glucose metabolism, insulin has shown to exert numerous vascular effects, and an impaired vascular function of insulin is assumed to be a major contributor in the development of vascular complications. Arterial augmentation (AP) and the augmentation index (Aix) are surrogate parameters of arterial stiffness and are commonly used as predictors for cardiovascular risk. The aim of this study is to investigate the effect of insulin on arterial stiffness and parameters of endothelial function in patients with type 1 diabetes and healthy control subjects. METHODS Fourteen patients with type 1 diabetes (six male, eight female) with a mean age of 36.6 +/- 11.8 …

medicine.medical_specialtyEndocrinology Diabetes and Metabolismmedicine.medical_treatmentBiomedical EngineeringBioengineering030204 cardiovascular system & hematology030218 nuclear medicine & medical imaging03 medical and health scienceschemistry.chemical_compound0302 clinical medicineDiabetes mellitusInternal medicineInternal MedicinemedicineNeurological and Microvascular FunctionType 1 diabetesbusiness.industryInsulinNitrotyrosineLitermedicine.diseasePulse pressureEndocrinologychemistryArterial stiffnessAsymmetric dimethylargininebusinessJournal of Diabetes Science and Technology
researchProduct

A multinational, multidisciplinary consensus for the diagnosis and management of spinal cord compression among patients with mucopolysaccharidosis VI.

2012

Cervical cord compression is a sequela of mucopolysaccharidosis VI, a rare lysosomal storage disorder, and has devastating consequences. An international panel of orthopedic surgeons, neurosurgeons, anesthesiologists, neuroradiologists, metabolic pediatricians, and geneticists pooled their clinical expertise to codify recommendations for diagnosing, monitoring, and managing cervical cord compression; for surgical intervention criteria; and for best airway management practices during imaging or anesthesia. The recommendations offer ideal best practices but also attempt to recognize the worldwide spectrum of resource availability. Functional assessments and clinical neurological examinations …

medicine.medical_specialtyEndocrinology Diabetes and Metabolismmedicine.medical_treatmentConsensus Development Conferences as TopicMucopolysaccharidosis type VIBiochemistryMyelopathyEndocrinologySpinal cord compressionGeneticsMedicineHumansIntensive care medicineMolecular BiologyMucopolysaccharidosis VIbusiness.industryStandard treatmentSequelaCervical cord compressionEnzyme replacement therapymedicine.diseaseSurgeryPractice Guidelines as TopicCervical VertebraeAirway managementbusinessSpinal Cord CompressionMolecular genetics and metabolism
researchProduct

Effects of exercise on inflammation markers in type 2 diabetic subjects

2011

Endothelial dysfunction and plasma markers of inflammation are significantly increased in type 2 diabetics. Several proinflammatory cytokines, acute-phase proteins, and cell adhesion molecules, such as C-reactive protein (CRP), interleukines (IL), and tumor necrosis factor alpha (TNF-α), seem to play a role in the low-grade systemic inflammation observed in these subjects. Lifestyle changes are necessary to prevent atherosclerosis and cardiovascular events. Physical exercise is known to reduce markers of inflammation by decreasing adipocytokine production and cytokine release from skeletal muscles, endothelial cells, and immune system and also improving antioxidant status. In type 2 diabeti…

medicine.medical_specialtyEndocrinology Diabetes and Metabolismmedicine.medical_treatmentInflammationPhysical exerciseSystemic inflammationProinflammatory cytokineEndocrinologyAdipokinesInternal medicinediabetesexerciseinflammation markersInternal MedicinemedicineHumansAerobic exerciseExerciseInflammationAdiponectinbusiness.industryGeneral MedicineExercise TherapyCytokineEndocrinologyDiabetes Mellitus Type 2CytokinesResistinmedicine.symptombusinessBiomarkersActa Diabetologica
researchProduct